Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease

Table 2

Demographic and clinical characteristics of Crohn’s disease and ulcerative colitis patients.

Variable	Non-inflamed Controls (n=30)	Inactive UC patients (n=20)	Active UC patients (n=30)	Inactive CD patients (n=10)	Active CD patients (n=10)
Age, years
Mean	48.9	40.8	39.05	49.3	25
Sex,	14/16	6/14	10/20	4/6	3/7
female/male
Treatment
Mesalazine	ND	19/20	19/30	1/10	1/10
Azathioprine	ND	4/20	1/30	5/10	3/10
Prednisone	ND	3/20	3/30	2/10	1/10
Mercaptopurine	ND	0/20	3/30	0/10	1/10
Disease
Extension	ND	7/20	1/30	1/10	0/10
Distal colitis	ND	12/20	8/30	7/10	6/10
Pancolitis
Extra-intestinal
manifestations
absent	ND	15/20	17/30	7/10	6/10
present	ND	4/20	12/30	1/10	0/10

CD: Crohn’s Disease patient group; UC: ulcerative colitis patient group. ND: not determined.